The Need for a Unified Protocol for Termination of Amblyopia Treatment

Abstract

Introduction Many authors have intensely investigated the management and outcomes of amblyopia treatment. Despite the fact that recurrence of amblyopia following cessation of treatment is expected there is no agreement on the exact incidence or the risk factors associated with visual regression (Tacagni et al. 2007; Gunton 2013; Nilsson, Baumann and Sjöstrand 2007). Current practice consists of an evidence-based approach to diagnose and treat amblyopia; however, the protocols for the cessation of treatment and duration of posttreatment follow-up remain arbitrary (Tacagni et al. 2007). Previous studies have suggested that maximal visual acuity is reached by 15 weeks of treatment and visual regression can occur in up to 67% following cessation of treatment (Gunton 2013), and usually within six months post-treatment (Nilsson, Baumann and Sjöstrand 2007). The published risk factors include the presence of microtropia, age at start of treatment, abrupt cessation of treatment, the amount of improvement in visual acuity, age at termination of amblyopia treatment and the final visual acuity (

Awareness and Attitude Towards Digital Screen-Based Binocular Vision Therapy Amongst Eye Care Practitioners of Karnataka

“…A retrospective study of patients discharged following treatment of amblyopia was studied by Nassar et al 71.8% of the patients were undergoing occlusion therapy and 28% were given with the combination therapy ( 14). The reasons for the above-mentioned strategy of management were experience and evidence-based practice.…”